Pathkey.AI Ltd (ASX:PKY)

Market Cap	27.01M +257.0%
Revenue (ttm)	47.63K +71.4%
Net Income	-3.65M
EPS	-0.01
Shares Out	1.35B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,918
Open	0.0200
Previous Close	0.0200
Day's Range	0.0200 - 0.0200
52-Week Range	0.0140 - 0.0750
Beta	1.53
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About Pathkey.AI

Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PKY

Financial Performance

In fiscal year 2026, Pathkey.AI's revenue was 47,632, an increase of 71.44% compared to the previous year's 27,783. Losses were -3.65 million, 152.3% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 20, 2026

Data Sources Report a data error